ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Breathwork: Digital Asthma Management with Professor Richard Costello"
Episode Synopsis
In this episode, Irish respiratory fellows Barry and Sandra sit down with Professor Richard Costello to explore the rapidly evolving world of digital asthma care. From eosinophils and T2 inflammation to the future of smart inhalers and precision monitoring, this conversation dives deep into how technology is reshaping diagnosis, adherence, and long-term management.
Professor Richard Costello discusses the challenges of diagnosing a highly variable disease, the limitations of symptom-based tools like the ACT, and why biomarkers and digital home spirometry are essential in modern asthma practice. They cover how digital devices can reveal patient behaviour, uncover hidden comorbidities, and distinguish difficult-to-treat asthma from true severe asthma.
The episode also explores the emerging potential of closed-loop smart inhalers, real-time lung function monitoring, and how personalised dosing may soon become a reality. Along the way, the team unpacks overlooked side effects of chronic inhaled steroids, the importance of steroid stewardship, and how Ireland can move toward a more decentralised, digitally enabled model of asthma care.
Chapters
00:00 – Introduction
00:31 – Episode Overview
01:15 – Rapid-Fire Round: True or False
03:45 – The Importance of Eosinophils & T2 InflammationDr. Costello explains why identifying T2 inflammation is central to diagnosing and managing asthma.
06:15 – Challenges in Diagnosing AsthmaVariability, biomarkers, bronchial responsiveness, and why asthma remains difficult to diagnose in 2025.
09:40 – The Role of Home SpirometryHow home monitoring helps differentiate asthma from mimics and guides treatment decisions.
12:10 – Differentiating Difficult-to-Treat vs Severe AsthmaUsing digital adherence data to distinguish true severity from difficult to treat asthma.
14:20 – The Future: Smart, Closed-Loop InhalersHow inhalers may soon auto-dose based on real-time airflow and physiology.
17:00 – Understanding the User, Not Just the DeviceDigital data reveals patient behaviour patterns and barriers to adherence.
20:10 – When Symptoms Aren’t AsthmaReflux, deconditioning, cardiac disease, and other asthma mimics uncovered through monitoring.
22:20 – Hidden Side Effects of High-Dose SteroidsAdrenal suppression, cataracts, diabetes, and why symptom-based escalation can lead to elevated steroid exposure.
25:00 – The Limitations of the ACT & Symptom ScoresWhy subjective questionnaires fall short in a multimorbid population.
27:10 – Ireland’s Future: Digital Home Monitoring & Decentralised CareHow integrated hubs and digital platforms could streamline diagnosis and management.
30:00 – Looking Ahead
31:29 – Closing Remarks
Guest: Professor Richard Costello
Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.
Hosts: Dr Barry Harnedy & Dr Sandra Green
Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.
Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health.
Professor Richard Costello discusses the challenges of diagnosing a highly variable disease, the limitations of symptom-based tools like the ACT, and why biomarkers and digital home spirometry are essential in modern asthma practice. They cover how digital devices can reveal patient behaviour, uncover hidden comorbidities, and distinguish difficult-to-treat asthma from true severe asthma.
The episode also explores the emerging potential of closed-loop smart inhalers, real-time lung function monitoring, and how personalised dosing may soon become a reality. Along the way, the team unpacks overlooked side effects of chronic inhaled steroids, the importance of steroid stewardship, and how Ireland can move toward a more decentralised, digitally enabled model of asthma care.
Chapters
00:00 – Introduction
00:31 – Episode Overview
01:15 – Rapid-Fire Round: True or False
03:45 – The Importance of Eosinophils & T2 InflammationDr. Costello explains why identifying T2 inflammation is central to diagnosing and managing asthma.
06:15 – Challenges in Diagnosing AsthmaVariability, biomarkers, bronchial responsiveness, and why asthma remains difficult to diagnose in 2025.
09:40 – The Role of Home SpirometryHow home monitoring helps differentiate asthma from mimics and guides treatment decisions.
12:10 – Differentiating Difficult-to-Treat vs Severe AsthmaUsing digital adherence data to distinguish true severity from difficult to treat asthma.
14:20 – The Future: Smart, Closed-Loop InhalersHow inhalers may soon auto-dose based on real-time airflow and physiology.
17:00 – Understanding the User, Not Just the DeviceDigital data reveals patient behaviour patterns and barriers to adherence.
20:10 – When Symptoms Aren’t AsthmaReflux, deconditioning, cardiac disease, and other asthma mimics uncovered through monitoring.
22:20 – Hidden Side Effects of High-Dose SteroidsAdrenal suppression, cataracts, diabetes, and why symptom-based escalation can lead to elevated steroid exposure.
25:00 – The Limitations of the ACT & Symptom ScoresWhy subjective questionnaires fall short in a multimorbid population.
27:10 – Ireland’s Future: Digital Home Monitoring & Decentralised CareHow integrated hubs and digital platforms could streamline diagnosis and management.
30:00 – Looking Ahead
31:29 – Closing Remarks
Guest: Professor Richard Costello
Professor Richard Costello is a professor of respiratory medicine at the Royal College of Surgeons in Ireland and a consultant at Beaumont Hospital, Dublin. He trained at RCSI, Beaumont, and Johns Hopkins University. A leading researcher in airways disease and digital respiratory health, he has published over 200 papers, holds several health innovation patents, and founded a company focused on inhaler adherence. He has served as Vice President of the Royal College of Physicians of Ireland and chaired the European Respiratory Society Educational Council, receiving the ERS Educational Award for his contributions to respiratory medicine.
Hosts: Dr Barry Harnedy & Dr Sandra Green
Dr Barry Harnedy is a respiratory specialist trainee in Ireland. He graduated from National University of Ireland Galway. He is the current Irish Thoracic Society co Educational Officer. He is passionate about digital innovation and airways assessment.
Dr Sandra Green is a respiratory specialist trainee in Ireland. She is the current Irish Thoracic Society Sustainability Officer. As a founder of Irish Doctors for the Environment she is interested in healthcare sustainability and planetary health.
In God we trust